CRO Network Alliance Expands
A Russian and Pakistani CRO Announce Network Alliance for Expansion of Global Clinical Trials Services
June 30, 2008
A Russian and Pakistani CRO Announce Network Alliance for Expansion of Global Clinical Trials Services
On June 30, 2008 Synergy Research Group (SynRG), a Russia-based CRO with more than 6-years experience in clinical trials in Russia announced the establishment of a new international CRO alliance with Metrics Research, a Pakistan-based CRO. This is the next step made by SynRG toward the formation of a CRO Worldwide Network capable to compete with global CROs in bids for large international multi-center clinical studies. The alliance currently includes CROs from the US, Europe, India, Pakistan and Ukraine.
“Pakistan with its 173 million strong population base, and a vast number of treatment-naïve patients, exactly like Russia, is one of the world’s emerging clinical trials market today. We are quite certain that both companies will benefit from allowing their clients the international capabilities. Together we are able to offer our sponsors access to more than 300 million patients,” said Elena Zhuk, General Director and CEO at SynRG.
“The Central and South Asian nexus is pivotal in providing clinical research services to the growing, evolving and competitive R&D industry of the world. Pakistan is already on the radar screen of multinational Pharma and CRO’s. Several Phase II, III FDA registration studies are currently ongoing in Pakistan. This ‘natural’ alliance between Metrics Research of Pakistan and SynRG of Russia will reap the benefits of this untapped market – Especially at a time when the government of Pakistan and relevant ministries are promoting clinical research activities in Pakistan”, stated Metrics Research’s Chief Executive, Khurram Zaki Khan.
Metrics Research is the first registered Contract Clinical Research and Site Management Organization (CRO/SMO) of Pakistan providing a comprehensive range of services in, project management, clinical operations and monitoring, data management, biostatistics, medical report writing, regulatory affairs, quality assurance, professional clinical research personnel training and development programs, country specific medical consultancy.
Igor Stefanov, SynRG’s Director for Business Development commented, “Now we're able to conduct trials in Pakistan also via our new partner. We are also planning some joint marketing and business development tasks – By preparing and sending proposals, and conduct presentations to the existing clients and prospects, and assist each other with related language and cultural translation issues.”
“Metrics Research’s mission is to forge collaborations and partnerships, to share knowledge and information, identify and/ or leverage common corporate strengths for business propagation and mutual profitability”, stated Faisal Roohi, Project and Business Development Manager for Metrics Research.
About SynRG
Synergy Research Group (SynRG™) is a Russian contract research organization, which has been successfully operating throughout Russia and the CIS member-states since 2002. SynRG™ offers a broad range of services for conducting clinical trials for Russian and foreign pharmaceutical and biotechnological companies – from regulatory affairs to pharmaco-economic surveys. The company has its own clinical depot in Moscow, with the total area of 1950 square feet. Today, Synergy Research Group is represented in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm and Almaty. The company’s headquarters are in Moscow.For more information, please visit www.synrg-pharm.com
About Metrics Research
Metrics Research is the first registered Contract Clinical Research and Site Management Organization (CRO/SMO) of Pakistan. Set up by the People Group of Companies, located in Karachi, it caters to the clinical development programs of the pharmaceutical, biotechnology and medical device industries at a global level.
For more information, please visit www.mrcro.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
